Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

749 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

NCT03303599

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Klinikum Klagenfurt am Woerthersee, Apotheke /ID# 169931 Klagenfurt, Carinthia, Austria

University Hospital St. Polten /ID# 169918 Sankt Pölten, Lower Austria, Austria

Medizinische Universität Graz /ID# 169932 Graz, Styria, Austria

Landeskrankenhaus Hall /ID# 169930 Hall in Tirol, Tyrol, Austria

View all 156 locations

View Trial Details

Completed

A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic

NCT03235154

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +20 more
Locations: Cambridge Health Alliance Outpatient Addiction Services Somerville, Massachusetts, United States

View Trial Details

Completed

International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife)

NCT03468673

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
Locations: University of Sydney Sydney, Australia

Center of treatment HIV/Aids - Brazil São Paulo, Brazil

Clinique m&dicale L'Actuel Montreal, Quebec, Canada

CHU de Bordeaux Bordeaux, France

View all 17 locations

View Trial Details

Completed

Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes

NCT02650024

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Ucsd Hnrp San Diego, California, United States

View Trial Details

Completed

Examining Hepatitis C Reinfection Rates in Kenya

NCT03564639

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: NASCOP Nairobi, Kenya

View Trial Details

Completed

STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention

NCT03706742

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +18 more
Locations: Parkland Hospital Dallas, Texas, United States

View Trial Details

Completed

A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects

NCT02760758

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Algorithme Montreal, Quebec, Canada

View Trial Details

Completed

Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive

NCT00945880

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Safety of Sofosbuvir in People With Advanced Kidney Failure

NCT03883698

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +21 more
Locations: Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, Uttar Pradesh, India

View Trial Details

Completed

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

NCT00758043

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Birmingham, Alabama, United States

Birmingham, Alabama, United States

Phoenix, Arizona, United States

Fresno, California, United States

View all 82 locations

View Trial Details